Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Biosimilar Retacrit, an Erythropoiesis-Stimulating Agent, Now Available

By Nov 14, 2018

Retacrit will be priced 57.1% below the Wholesale Acquisition Cost (WAC) of Procrit and 33.5% below the WAC of Epogen, at $11.03 per 1000 Units/mL.

Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation

By Nov 13, 2018

NRX-101 combines D-cycloserine (DCS), an N-methyl-D-aspartate (NMDA) receptor antagonist, and lurasidone, a D2/5-HT2a receptor antagonist.

Low-Dose Methotrexate Does Not Reduce Events in Stable Atherosclerosis

By Nov 13, 2018

Low-dose methotrexate did not result in a reduced number of cardiovascular events among patients with stable atherosclerosis.

HHS: Updated Physical Activity Guidelines for Americans Released

By Nov 12, 2018

This guidance, updated for the first time since 2008, provides evidence-based recommendations for children (ages 3-17) and adults.

Several Asthma, Allergy Groups Express "Deep Concern" Over Primatene MIST Approval

By Nov 12, 2018

Primatene MIST was approved earlier this month for over-the-counter (OTC) use for the temporary relief of mild symptoms of intermittent asthma (eg, wheezing, tightness of chest, shortness of breath) in patients aged ≥12 years.

More Articles by Da Hee Han, PharmD